N4 Pharma books loss as it invests in vaccine delivery system

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

N4 Pharma booked a first-half loss as it continued to invest in the development of its vaccine delivery system for cancer treatments.

Pre-tax losses for the six months through June amounted to £0.55m, compared to losses of £0.53 on-year.

The company had cash of around £1.2m at the end of June.

  •